Cardiol Historical Financial Ratios

CRDL Stock  CAD 1.93  0.10  4.93%   
Cardiol Therapeutics is presently reporting on over 90 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 2.38 or Days Sales Outstanding of 1.5 K will help investors to properly organize and evaluate Cardiol Therapeutics financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Cardiol Financial Ratios Analysis

Cardiol TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Cardiol Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Cardiol financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Cardiol Therapeutics history.

Cardiol Therapeutics Financial Ratios Chart

At this time, Cardiol Therapeutics' Graham Number is very stable compared to the past year. As of the 13th of December 2024, Shareholders Equity Per Share is likely to grow to 0.64, while PTB Ratio is likely to drop 2.38.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Cardiol Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Cardiol Therapeutics sales, a figure that is much harder to manipulate than other Cardiol Therapeutics Class multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Operating Cash Flow Per Share

A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.

Average Inventory

The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.
Most ratios from Cardiol Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Cardiol Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Cardiol Therapeutics' Graham Number is very stable compared to the past year. As of the 13th of December 2024, Shareholders Equity Per Share is likely to grow to 0.64, while PTB Ratio is likely to drop 2.38.
 2023 2024 (projected)
Days Sales Outstanding1.7K1.5K
PTB Ratio2.512.38

Cardiol Therapeutics fundamentals Correlations

0.421.0-0.07-0.21-0.32-0.480.30.421.0-0.320.46-0.490.190.470.140.451.0-0.110.930.5-0.420.93-0.540.890.39
0.420.42-0.780.550.64-0.440.121.00.420.640.33-0.790.80.87-0.29-0.480.41-0.770.410.86-0.730.41-0.770.50.32
1.00.42-0.07-0.21-0.32-0.480.30.421.0-0.320.46-0.490.190.470.140.451.0-0.110.930.5-0.420.93-0.540.890.39
-0.07-0.78-0.07-0.54-0.850.46-0.19-0.78-0.07-0.840.180.51-0.77-0.50.040.42-0.080.97-0.02-0.480.67-0.020.71-0.090.11
-0.210.55-0.21-0.540.64-0.410.060.55-0.210.63-0.26-0.50.210.47-0.03-0.63-0.2-0.59-0.240.42-0.45-0.24-0.54-0.27-0.37
-0.320.64-0.32-0.850.64-0.09-0.140.64-0.321.0-0.22-0.230.750.34-0.34-0.62-0.31-0.74-0.370.31-0.38-0.37-0.35-0.26-0.07
-0.48-0.44-0.480.46-0.41-0.09-0.23-0.44-0.48-0.080.280.470.0-0.43-0.37-0.02-0.470.55-0.49-0.440.43-0.490.85-0.270.49
0.30.120.3-0.190.06-0.14-0.230.120.3-0.16-0.07-0.440.060.00.810.310.29-0.330.32-0.02-0.760.32-0.480.41-0.06
0.421.00.42-0.780.550.64-0.440.120.420.640.33-0.790.80.87-0.29-0.480.41-0.770.410.86-0.730.41-0.770.50.32
1.00.421.0-0.07-0.21-0.32-0.480.30.42-0.320.46-0.490.190.470.140.451.0-0.110.930.5-0.420.93-0.540.890.39
-0.320.64-0.32-0.840.631.0-0.08-0.160.64-0.32-0.22-0.230.750.34-0.35-0.62-0.31-0.73-0.370.31-0.37-0.37-0.34-0.27-0.07
0.460.330.460.18-0.26-0.220.28-0.070.330.46-0.22-0.490.250.59-0.52-0.180.450.140.470.61-0.130.470.070.650.9
-0.49-0.79-0.490.51-0.5-0.230.47-0.44-0.79-0.49-0.23-0.49-0.41-0.890.010.42-0.480.65-0.49-0.870.8-0.490.75-0.59-0.28
0.190.80.19-0.770.210.750.00.060.80.190.750.25-0.410.5-0.36-0.320.19-0.640.170.5-0.580.17-0.410.360.48
0.470.870.47-0.50.470.34-0.430.00.870.470.340.59-0.890.5-0.41-0.570.45-0.580.471.0-0.550.47-0.630.530.39
0.14-0.290.140.04-0.03-0.34-0.370.81-0.290.14-0.35-0.520.01-0.36-0.410.560.13-0.080.16-0.42-0.360.16-0.320.07-0.53
0.45-0.480.450.42-0.63-0.62-0.020.31-0.480.45-0.62-0.180.42-0.32-0.570.560.470.450.36-0.540.140.360.120.27-0.04
1.00.411.0-0.08-0.2-0.31-0.470.290.411.0-0.310.45-0.480.190.450.130.47-0.10.90.49-0.410.9-0.530.860.38
-0.11-0.77-0.110.97-0.59-0.740.55-0.33-0.77-0.11-0.730.140.65-0.64-0.58-0.080.45-0.1-0.08-0.550.75-0.080.79-0.140.17
0.930.410.93-0.02-0.24-0.37-0.490.320.410.93-0.370.47-0.490.170.470.160.360.9-0.080.52-0.431.0-0.550.940.4
0.50.860.5-0.480.420.31-0.44-0.020.860.50.310.61-0.870.51.0-0.42-0.540.49-0.550.52-0.530.52-0.630.570.41
-0.42-0.73-0.420.67-0.45-0.380.43-0.76-0.73-0.42-0.37-0.130.8-0.58-0.55-0.360.14-0.410.75-0.43-0.53-0.430.82-0.55-0.14
0.930.410.93-0.02-0.24-0.37-0.490.320.410.93-0.370.47-0.490.170.470.160.360.9-0.081.00.52-0.43-0.550.940.4
-0.54-0.77-0.540.71-0.54-0.350.85-0.48-0.77-0.54-0.340.070.75-0.41-0.63-0.320.12-0.530.79-0.55-0.630.82-0.55-0.480.17
0.890.50.89-0.09-0.27-0.26-0.270.410.50.89-0.270.65-0.590.360.530.070.270.86-0.140.940.57-0.550.94-0.480.63
0.390.320.390.11-0.37-0.070.49-0.060.320.39-0.070.9-0.280.480.39-0.53-0.040.380.170.40.41-0.140.40.170.63
Click cells to compare fundamentals

Cardiol Therapeutics Account Relationship Matchups

Cardiol Therapeutics fundamentals Accounts

201920202021202220232024 (projected)
Ptb Ratio8.066.251.320.832.512.38
Book Value Per Share1.450.570.441.760.840.64
Free Cash Flow Yield(0.0998)(0.11)(0.23)(0.63)(3.56E-4)(3.74E-4)
Operating Cash Flow Per Share(0.71)(0.44)(0.31)(0.54)(3.91E-4)(4.1E-4)
Capex To Depreciation2.820.180.05860.342.59E-42.46E-4
Pb Ratio8.066.251.320.832.512.38
Free Cash Flow Per Share(0.46)(0.31)(0.55)(0.44)(3.92E-4)(4.11E-4)
Roic(0.95)(1.55)(0.47)(0.36)(1.05)(1.1)
Net Income Per Share(0.54)(0.69)(0.57)(0.18)(0.44)(0.46)
Payables Turnover0.0427268.26129.670.02630.02370.0225
Cash Per Share0.270.471.940.950.540.62
Pocfratio(10.39)(9.04)(4.28)(1.58)(2.8K)(2.7K)
Capex To Operating Cash Flow(0.0373)(0.00442)(5.48E-4)(0.002745)(0.002554)(0.002682)
Pfcf Ratio(10.02)(9.0)(4.27)(1.58)(2.8K)(2.7K)
Days Payables Outstanding8.5K1.362.8113.9K12.5K13.1K
Income Quality0.830.450.740.888.95E-48.5E-4
Roe(0.95)(1.56)(0.32)(0.22)(1.0)(1.05)
Ev To Operating Cash Flow(9.8)(7.53)(0.72)0.6(1.4K)(1.4K)
Pe Ratio(8.46)(4.02)(4.07)(3.74)(2.52)(2.65)
Return On Tangible Assets(0.94)(1.34)(0.28)(0.19)(0.77)(0.81)
Ev To Free Cash Flow(9.45)(7.49)(0.72)0.6(1.4K)(1.4K)
Earnings Yield(0.23)(0.12)(0.25)(0.27)(0.4)(0.42)
Intangibles To Total Assets0.03540.02920.0043160.0047530.0057320.005445
Net Debt To E B I T D A0.50.682.181.931.251.03
Current Ratio20.815.947.536.274.364.14
Tangible Book Value Per Share1.410.550.431.760.830.63
Shareholders Equity Per Share1.450.570.441.760.840.64
Capex Per Share8.97E-40.01640.001362.99E-40.0011951.0E-6
Graham Net Net0.290.391.680.80.410.55
Enterprise Value Over E B I T D A(8.24)(3.39)(0.44)0.53(1.3)(1.36)
Price Earnings Ratio(8.46)(4.02)(4.07)(3.74)(2.52)(2.65)
Price Book Value Ratio8.066.251.320.832.512.38

Pair Trading with Cardiol Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardiol Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cardiol Stock

  0.86AEMC Alaska Energy MetalsPairCorr
  0.77CMC Cielo Waste Solutions Earnings Call This WeekPairCorr

Moving against Cardiol Stock

  0.81MATE Blockmate VenturesPairCorr
  0.75LQWD LQwD FinTech CorpPairCorr
The ability to find closely correlated positions to Cardiol Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardiol Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardiol Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardiol Therapeutics Class to buy it.
The correlation of Cardiol Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardiol Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardiol Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardiol Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cardiol Therapeutics is a strong investment it is important to analyze Cardiol Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cardiol Therapeutics' future performance. For an informed investment choice regarding Cardiol Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Please note, there is a significant difference between Cardiol Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiol Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiol Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.